HCW Biologics shares skyrocketed as the company entered a licensing agreement with China's WY Biotech for an immunotherapeutic product candidate.

China's stock market is likely headed for tougher times ahead, at least according to a few prominent Wall Street firms.

The FTSE 100 and European markets opened higher on Monday, heading higher from a dip last week where investors took profits ...

Ford has more than a century of history and innovation behind it, but now BYD, a young Chinese automaker, is barreling around ...

Futu Holdings (NASDAQ:FUTU) is scheduled to announce Q3 earnings results on Tuesday, November 19th, before market open. The ...

We recently published a list of 10 Best Nickel Stocks to Invest in According to Analysts. In this article, we are going to ...

The CSRC will continue to work with Hong Kong regulators to connect international investors with the mainland’s markets, CSRC ...

CLSA's equity strategist said that even though the market still looks a bit expensive relative to what may be warranted, it ...

Nvidia's stock has surged more than 2,600% in the past five years according to Yahoo Finance data, fueled by one impressive ...

When we investigated some of the claims cited in the posts, we found that some were accurate, some were wrong and most of the rest omitted context ...

Chinese electric scooter company Niu Technologies (NASDAQ:NIU) reported a fiscal third-quarter 2024 revenue growth of 10.5% ...

Last week’s selloff, which comes on the heels of what has been a generally successful earnings season for Corporate America, ...